Institutional Pharmacy Business definition

Institutional Pharmacy Business means the Company’s business of providing independent pharmaceutical dispensing services to long-term care facilities and alternate site settings, including skilled nursing facilities, assisted living facilities and residential living communities, which services include the purchasing, repackaging and dispensing of pharmaceuticals, both prescription and non-prescription, and the delivery of such pharmaceuticals to healthcare facilities for administration, as well as various supplemental healthcare services that complement such pharmacy services.
Institutional Pharmacy Business means the business of providing pharmaceutical supplies and services primarily to health care institutions such as the Skilled Nursing Business conducted by GranCare and its Pharmacy Subsidiaries. 2
Institutional Pharmacy Business means the business of providing pharmaceutical products and services by Beve▇▇▇ ▇▇▇ough its Pharmacy Subsidiaries (including but not limited to Medicare Part B services and supplies), primarily to health care institutions, including but not limited to certain sub-acute and long-term health care facilities forming part of the Remaining Health Care Business conducted by Beve▇▇▇.

Examples of Institutional Pharmacy Business in a sentence

  • There exist no restrictions on the disclosure, use, license or transfer of the RhinoRx Intellectual Property owned by Rhino and its Subsidiaries (to the extent relating to the Rhino Institutional Pharmacy Business) (the “Owned RhinoRx Intellectual Property”).

  • There exist no restrictions on the disclosure, use, license or transfer of the HippoRx Intellectual Property owned by Hippo and its Subsidiaries (to the extent relating to the Hippo Institutional Pharmacy Business) (the “Owned HippoRx Intellectual Property”).

  • Except as set forth in Section 10.03 of the Rhino Disclosure Schedule, all intercompany accounts between Rhino or its Subsidiaries (other than the Rhino Institutional Pharmacy Business), on the one hand, and the Rhino Institutional Pharmacy Business, on the other hand, as of the Effective Time shall be settled (irrespective of the terms of payment of such intercompany accounts) subject to the provisions of this Section 10.03 and in the manner provided in this Section 10.03.

  • Rhino beneficially owns no interests in any Person engaged in the Rhino Institutional Pharmacy Business other than the RhinoRx Entities.

  • If the RhinoRx Final Financing Amount together with cash on hand of the Rhino Institutional Pharmacy Business is not sufficient to pay all such intercompany balances, the remaining balances shall be cancelled at the Effective Time.

  • Rhino has furnished to Hippo a list of, and true and complete copies of, all insurance policies and fidelity bonds relating to the Rhino Institutional Pharmacy Business and its officers and employees.

  • If the HippoRx Final Financing Amount together with cash on hand of the Hippo Institutional Pharmacy Business is not sufficient to pay all such intercompany account balances, the remaining balances shall be cancelled at the Effective Time.

  • To the knowledge of Hippo, no HippoRx Entity is engaged in any business other than the Hippo Institutional Pharmacy Business or has any Liabilities relating to any other business.

  • As soon as practicable, but in no event later than March 31, 2007, Rhino shall deliver to Hippo, the audited balance sheet as of December 31, 2006 and the related audited statements of income and cash flows for the year ended December 31, 2006 for the Rhino Institutional Pharmacy Business.

  • The parties agree that such services shall be substantially similar in scope to the services provided by the Hippo Institutional Pharmacy Business to the Hippo Workers’ Compensation Business immediately prior to the Distribution Time.